Brian Santich

Q: What is Brian Santich email address?

Email Brian Santich at bsantich@ymabs.com. This email is the most updated Brian Santich email found in 2026.

Q: How to contact Brian Santich?

To contact Brian Santich send an email to bsantich@ymabs.com. (updated on November 04, 2024)

Vice President Research And Development at Y-mAbs Therapeutics, Inc. | New York City Metropolitan Area

About Brian Santich

Brian Santich is a seasoned PhD Scientist with over a decade of extensive experience in oncology and immunology, currently serving as Senior Director at Y-mAbs Therapeutics, Inc. In this pivotal role, Brian leads a dynamic team of six scientists dedicated to the discovery, selection, and characterization of innovative bispecific antibody therapeutics aimed at combating various forms of cancer. His expertise in protein engineering and assay development is instrumental in driving the preclinical drug development process, ensuring that promising candidates are not only identified but also rigorously characterized for their therapeutic potential.

Brian's collaborative approach is a cornerstone of his leadership style, as he works closely with cross-functional teams, including medical, commercial, business development, and CMC manufacturing, to facilitate the seamless transition of research and development products from the lab to clinical trials and, ultimately, to market approval. His contributions have been vital in the successful preparation of non-clinical packages for multiple Investigational New Drug (IND) applications, showcasing his proficiency in navigating the complexities of regulatory requirements.

With a strong foundation in biochemistry and biotechnology, Brian has filed 11 patents—one of which has been licensed for clinical development—demonstrating his commitment to innovation in the field. His ability to blend scientific rigor with strategic business acumen positions him as a key player in advancing Y-mAbs Therapeutics' mission to develop life-saving therapies. Brian's dedication to public speaking and project management further enhances his capability to lead initiatives that drive the company's vision forward, making him an invaluable asset in the ever-evolving landscape of cancer therapeutics.

Brian Santich Work